VSEE news

VSee Health filed an amendment to its charter to implement an 80-for-1 reverse stock split.

VSee Health signed a purchase agreement with Cleartthink Capital Partners for the sale of up to $5 million in common stock and issued a commitment fee of 40,000 restricted shares.

VSee Health agrees to sell a convertible promissory note with a $336,000 principal amount and $300,000 purchase price to Labrys Fund II on June 30, 2026, for legal and due diligence fees. Stock offering.

VSee Health entered into a securities purchase agreement to issue a promissory note with original issue discount to ADI Funding LLC. The company plans to use proceeds from an equity line of credit arrangement to repay the note and intends to file a Form S-1 registration statement.

VSee Health is divesting its VSee Lab subsidiary to founder Milton Chen through a stock purchase agreement effective May 31, 2026, allowing the company to operate independently. The transaction represents a significant restructuring as Chen separates from his dual executive roles at both entities.